CD274 and neoplasm: These nanoparticles increased the effector T cell infiltration in solid tumors by reducing the tumor’s fibrosis and tumor-resident MDSCs and Treg cells, subsequently enhancing the effectiveness of the PD-1/PD-L1 immunotherapy both in vivo and in vitro.